PEN · Penumbra Inc
United States · RS rating 63 · As of 2026-11-03
| Price | 320.02 USD |
|---|---|
| 1-day change | -0.4% |
| RS rating (overall / 1M / 3M / 12M) | 63 / 60 / 64 / 81 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 37 / 35 / 35 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | +2.6% |
| Sales growth Q/Q | +8.7% |
| Distance from 52-week high | +11.0% |
| Market cap (USD) | $13.1B |